España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Gossamer Bio
GOSS
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.695600
0.03
4.66%
At close: -
$0.690200
-0.0054
-0.78%
After Hours: Nov 22, 5:39 PM EDT
Get Report
Comment
Gossamer Bio (GOSS) Forecast
News
Earnings
Gossamer Bio (GOSS) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Gossamer Bio (NASDAQ:GOSS) Stock
Gossamer Bio Stock (NASDAQ: GOSS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, November 11, 2024
HC Wainwright & Co. Reiterates Buy on Gossame...
Benzinga Newsdesk
Thursday, November 07, 2024
Gossamer Bio Q3 2024 GAAP EPS $(0.14), Inline
Benzinga Newsdesk
Wednesday, October 02, 2024
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
Tuesday, September 17, 2024
HC Wainwright & Co. Reiterates Buy on Gossame...
Benzinga Newsdesk
Friday, August 30, 2024
HC Wainwright & Co. Reiterates Buy on Gossame...
Benzinga Newsdesk
Monday, August 26, 2024
Gossamer Bio Announced Two Oral Presentations...
Benzinga Newsdesk
Tuesday, August 13, 2024
Wedbush Reiterates Outperform on Gossamer Bio...
Benzinga Newsdesk
Monday, August 12, 2024
Gossamer Bio Q2 2024 GAAP EPS $0.22 Beats $0....
Benzinga Newsdesk
Tuesday, June 25, 2024
Gossamer Bio's Clean Safety Profile Differentiates It From Merck, Analyst Says
Vandana Singh
Gossamer Bio And 2 Other Stocks Under $2 Insiders Are Buying
Avi Kapoor
Gossamer Bio shares are trading higher after ...
Benzinga Newsdesk
Oppenheimer Initiates Coverage On Gossamer Bi...
Benzinga Newsdesk
Friday, June 21, 2024
Why Kaival Brands Innovations Shares Are Trading Lower By 47%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Monday, June 17, 2024
Goldman Sachs Maintains Buy on Gossamer Bio, ...
Benzinga Newsdesk
Gossamer Bio shares are trading higher after ...
Benzinga Newsdesk
Tuesday, June 11, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Monday, May 20, 2024
HC Wainwright & Co. Reiterates Buy on Gossame...
Benzinga Newsdesk
Tuesday, May 14, 2024
Gossamer Bio Provides Updated Seralutinib TOR...
Benzinga Newsdesk
Monday, May 13, 2024
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Wednesday, May 08, 2024
Wedbush Reiterates Outperform on Gossamer Bio...
Benzinga Newsdesk
Tuesday, May 07, 2024
Gossamer Bio Q1 EPS $(0.19) Misses $(0.18) Es...
Benzinga Newsdesk
Monday, May 06, 2024
Gossamer Bio Collaborates With Italian Drugmaker Chiesi To Advance Lung Health Solutions Worldwide
Vandana Singh
HC Wainwright & Co. Reiterates Buy on Gossame...
Benzinga Newsdesk
Watching Gossamer Bio; Traders Circulate Unco...
Benzinga Newsdesk
Trading Halt: Halt status updated at 7:55:00 ...
Benzinga Newsdesk
Gossamer Bio Secures $160M Partnership with C...
Benzinga Newsdesk
Trading Halt: Halted at 7:25:00 a.m. ET - Tra...
Benzinga Newsdesk
Friday, May 03, 2024
Gossamer Bio Published TORREY Phase 2 Results...
Benzinga Newsdesk
Thursday, April 25, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Friday, April 05, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Wedbush Assumes Gossamer Bio at Outperform, A...
Benzinga Newsdesk
Wednesday, March 27, 2024
Piper Sandler Maintains Overweight on Gossame...
Benzinga Newsdesk
Wednesday, March 06, 2024
Goldman Sachs Maintains Buy Rating for Gossamer Bio: Here's What You Need To Know
Benzinga Insights
Goldman Sachs Maintains Buy on Gossamer Bio, ...
Benzinga Newsdesk
Wedbush Reiterates Outperform on Gossamer Bio...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Gossame...
Benzinga Newsdesk
Tuesday, March 05, 2024
Gossamer Bio Q4 EPS $(0.21), Inline; Cash, Ca...
Benzinga Newsdesk
Monday, March 04, 2024
On March 4, 2024, Gossamer Bio Received Lette...
Benzinga Newsdesk
Tuesday, February 20, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
Monday, January 08, 2024
HC Wainwright & Co. Maintains Buy Rating for Gossamer Bio: Here's What You Need To Know
Benzinga Insights
HC Wainwright & Co. Maintains Buy on Gossamer...
Benzinga Newsdesk
Tuesday, December 19, 2023
Wedbush Reiterates Outperform on Gossamer Bio...
Benzinga Newsdesk
Monday, December 18, 2023
Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Monday, December 04, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Thursday, November 30, 2023
Gossamer Bio Director Awarded $165K Worth of Stock Options
Benzinga Insights
Thursday, November 23, 2023
Gossamer Bio Chief Medical Officer Awarded $121K Worth of Stock Options
Benzinga Insights
EVP at Gossamer Bio Acquires Company Stock Options Worth 125,000 Shares
Benzinga Insights
President & CEO at Gossamer Bio Acquires Company Stock Options Worth 437,500 Shares
Benzinga Insights
Wednesday, November 15, 2023
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch